BRII BIOSCIENCES
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
BRII BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Innovation Management Pharmaceutical
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
415 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving Apache Global Site Tag
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Enveda Biosciences
Enveda Biosciences is a biotechnology company building new medicines from plants.
EQRx
EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Invesco
Invesco investment in Series C - Brii Biosciences
Proioxis Ventures Fund
Proioxis Ventures Fund investment in Series C - Brii Biosciences
GIC
GIC investment in Series C - Brii Biosciences
Lake Bleu Capital
Lake Bleu Capital investment in Series C - Brii Biosciences
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - Brii Biosciences
6 Dimensions Capital
6 Dimensions Capital investment in Venture Round - Brii Biosciences
Sequoia Capital China
Sequoia Capital China investment in Venture Round - Brii Biosciences
Blue Pool Capital
Blue Pool Capital investment in Venture Round - Brii Biosciences
YF Capital
YF Capital investment in Venture Round - Brii Biosciences
Boyu Capital
Boyu Capital investment in Venture Round - Brii Biosciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-11-21 | AN2 Therapeutics | Brii Biosciences investment in Series A - AN2 Therapeutics | 12 M USD |
| 2019-06-11 | Artizan Biosciences | Brii Biosciences investment in Series A - Artizan Biosciences | 12 M USD |
Key Employee Changes
More informations about "Brii Biosciences"
Brii Biosciences - Crunchbase Investor Profile & Investments
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's …See details»
Brii Biosciences Provides Latest Clinical Development …
Jul 5, 2023 Brii Biosciences is a biotechnology company developing therapies to address some of the world's most common diseases where patients experience high unmet medical needs, limited choice and ...See details»
Brii Biosciences Company Profile - Office Locations ... - Craft
Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. …See details»
Brii Biosciences (HKG:2137) Company Profile & Description - Stock …
May 2, 2025 Brii Biosciences Limited engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United …See details»
Brii Biosciences Closes US$155 Million Series C Financing
Mar 23, 2021 Brii Biosciences (Brii Bio) is a multi-national company committed to serving patients' needs and improving public health by accelerating the development and delivery of …See details»
Brii Biosciences Provides Corporate Update and Reports Full
Mar 24, 2025 Brii Biosciences Limited ("Brii Bio," stock code: 2137.HK) is a biotechnology company developing therapies to address major public health challenges where patients …See details»
Brii Biosciences Provides Latest Clinical Development and …
Jul 6, 2023 Dr. David Margolis appointed as Chief Medical Officer to lead organization's late-stage clinical programs towards commercialization. DURHAM, N.C. and BEIJING, July 6, 2023 …See details»
Brii Biosciences Provides Corporate Update and …
Aug 24, 2022 Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant …See details»
VBI Vaccines and Brii Biosciences Expand Hepatitis B Partnership …
Jul 5, 2023 Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri® in the Asia Pacific region; ... (IAC), a non-profit organization …See details»
Brii Biosciences Provides Corporate Update and …
Mar 22, 2024 Brii Biosciences Limited ("Brii Bio", stock code: 2137.HK) is a biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical ...See details»
Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 …
May 7, 2025 DURHAM, N.C. and BEIJING, May 7, 2025 /PRNewswire/ -- Brii Biosciences Limited (" Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company …See details»
Brii Bio Announces Signing of Asset Purchase Agreements …
Dec 31, 2024 Brii Biosciences Limited ("Brii Bio," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across …See details»
About Us | Brii Biosciences
We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations. Brii Biosciences is a biotechnology company developing therapies to address …See details»
Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific …
Jan 3, 2024 Brii Biosciences Limited ("Brii Bio", stock code: 2137.HK) is a commercial stage biotechnology company developing therapies to address major public health challenges where …See details»
Brii Biosciences Provides Corporate Update and Reports Full Year …
Mar 22, 2022 Brii Biosciences Limited ("Brii Bio," or the "Company," stock code: 2137.HK) is a biotechnology company based in China and the U.S. and is committed to advancing therapies …See details»
Leadership | Brii Biosciences
We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations. Brii Biosciences is a biotechnology company developing therapies to address …See details»
Press Release | Brii Biosciences
Mar 22, 2024 We innovate and advance novel therapies to provide greater choice and freedom to broad patient populations. Brii Biosciences is a biotechnology company developing …See details»
騰盛博藥在2025年EASL大會上公布了其正在進行的ENSURE 2期研 …
6 days ago ENSURE 研究隊列 4 的治療結束（ EOT ）數據表明，對既往 BRII-179 治療有應答的患者在接受治愈性治療後相較 BRII-179 ... World Health Organization. (April 2024 ...See details»
Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 …
6 days ago Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across …See details»
Brii Biosciences Provides Corporate Update and Reports Full-Year …
Mar 21, 2025 Brii Biosciences Limited ("Brii Bio," stock code: 2137.HK) is a biotechnology company developing therapies to address major public health challenges where patients …See details»